Long-term results of anti-IgE-therapy in severe uncontrolled child asthma.

Conclusions: the anti-IgE-therapy (omalizumab) for children with severe uncontrolled asthma is highly effective and safe.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Diakova, S., Mizernitskyi, Y., Sokolova, L., Sorokina, E., Zorina, I. Tags: Airway pharmacology and treatment Source Type: research